Prosecution Insights
Last updated: August 17, 2026

Examiner: ZOU, NIANXIANG

Tech Center 1600 • Art Units: 1600 1642 1648 1671 1675

This examiner grants 64% of resolved cases

Performance Statistics

64.0%
Allow Rate
+4.0% vs TC avg
810
Total Applications
+24.4%
Interview Lift
990
Avg Prosecution Days
Based on 770 resolved cases, 2023–2026

Rejection Statute Breakdown

6.7%
§101 Eligibility
15.2%
§102 Novelty
34.3%
§103 Obviousness
26.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18344952 METHODS FOR DETERMINING SARS-COV-2 ANTIGEN AND ANTI-SARS-COV-2 ANTIBODY IN A SAMPLE Final Rejection Abbott Laboratories
18560515 Coronavirus Constructs and Vaccines Non-Final OA The Regents of the University of California
17800687 Multilamellar RNA Nanoparticles and Methods of Sensitizing Tumors to Treatment with Immune Checkpoint Inhibitors Non-Final OA UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
18021719 RAPID AND LOW-COST NUCLEIC ACID DETECTION USING TRANSLATION-BASED SEQUENCE VERIFICATION ASSAYS Final Rejection ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
18016932 METHODS OF DIAGNOSTICS Non-Final OA TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED
18415814 METHOD OF DETECTING SARS-COV IN A SAMPLE Non-Final OA Imam Abdulrahman Bin Faisal University

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month